|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Departments of Cardiothoracic Anesthesia and Intensive Care (Drs. Jörgensen, Houltz, and Ricksten) and Radiology (Dr. Müller and Ms. Nel), Sahlgrenska University Hospital, Gothenburg, Sweden; and Department of Anesthesia and Intensive Care (Dr. Upton), Royal Adelaide Hospital and University of Adelaide, Adelaide, Australia.
Correspondence to: Sven-Erik Ricksten, MD, PhD, Department of Cardiothoracic Anesthesia and Intensive Care, Sahlgrenska University Hospital, S-413 45 Gothenburg, Sweden; e-mail: sven-erik.ricksten{at}aniv.gu.se
Abstract
Background: Left ventricular (LV) filling is impaired in patients with severe emphysema manifesting in small end-diastolic dimensions. We hypothesized that the hyperinflated lungs of these patients with high intrinsic positive end-expiratory pressure will decrease intrathoracic blood volume (ITBV) and ventricular preload. We therefore measured ITBV, and LV and right ventricular (RV) dimensions and function using MRI techniques in patients with severe emphysema.
Methods: Patients with severe emphysema (n = 13) and matched healthy volunteers (n = 11) were included. The magnetic resonance (MR) examination consisted of three parts: (1) evaluation of RV and LV dimensions and function and interventricular septum curvature using cine MRI; (2) quantification of aortic flow using MR phase velocity mapping; and (3) calculation of the cardiopulmonary peak transit time (PTT) from the pulmonary artery to the ascending aorta using contrast-enhanced, time-resolved, two-dimensional MR angiography.
Results: There were no differences between the groups regarding age, height, or weight. In the emphysema patients, ITBV index ( 35%), LV end-diastolic volume index (LVEDVI) [ 21%], RV end-diastolic volume index ( 20%), cardiac index ( 22%), and stroke volume index (SVI) [ 40%] were lower compared to control subjects. LV and RV end-systolic volumes, LV wall mass, septal curvature, and PTT did not differ between the groups. LVEDVI (r = 0.83) as well as SVI (r = 0.82) correlated closely to ITBV index. SVI correlated closely to LVEDVI (r = 0.84).
Conclusions: LV and RV performance is impaired in patients with severe emphysema because of small end-diastolic dimensions. One possible explanation for the decreased biventricular preload in these patients is intrathoracic hypovolemia caused by hyperinflated lungs.
Key Words: biventricular end-diastolic volumes biventricular function cardiac output emphysema intrathoracic blood volume mean transit time MRI
Patients with severe lung emphysema have poor quality of life because of impaired lung function and considerable reduction in exercise tolerance.1 The functional features consist of severe expiratory airflow obstruction and considerable hyperinflation due to destruction of lung parenchyma and loss of lung elasticity. Intrathoracic (intrapleural) pressure is increased due to generation of a high intrinsic positive end-expiratory pressure (PEEPi).23
We have studied4 left ventricular (LV) diastolic and systolic function in patients with severe emphysema and found that LV function is impaired in patients with severe emphysema due to small LV end-diastolic dimensions, ie, a decrease in LV preload. The present investigation is an extension of that study, and the aim was to evaluate whether or not the hyperinflated lungs in patients with severe emphysema will cause blood to pool peripherally and thus decrease intrathoracic blood volume (ITBV) and LV and right ventricular (RV) end-diastolic volumes (preload), stroke volume (SV), and stroke work.5 We therefore measured ITBV and LV and RV dimensions and function in patients with severe emphysema using MRI techniques.
Materials and Methods
The local Ethics Committee of the Medical Faculty of Göteborg University approved the study protocol, written informed consent was obtained from all subjects, and the study complied with the recommendations found in the Declaration of Helsinki.6 Criteria for inclusion in the emphysema group (n = 13) were a history of lung emphysema based on physical examination, chest radiography, and pulmonary function test results: FEV1 from 15 to 30% of predicted value; total lung capacity > 120% of predicted value; and residual volume > 200% of predicted value. Furthermore, the emphysema patients should have no history of cardiac disease, a normal echocardiographic examination (LV ejection fraction > 50% and systolic pulmonary artery [PA] pressure < 55 mm Hg). These criteria are in concordance with commonly accepted guidelines for single-lung transplantation.7 The control group consisted of healthy volunteers (n = 11) with no history of cardiopulmonary disease and were matched for age, gender, and body size.
Imaging Protocol
Each subject underwent a single magnetic resonance (MR) examination (1.5-T MR system, Philips Intera, R9.3; Philips Medical Systems; Best, the Netherlands). [Figs 123456
]. Heart rate was continuously recorded, and systolic and diastolic arterial BPs (by sphygmomanometer) were recorded before the start of imaging. Subjects in the emphysema group were allowed to breathe oxygen-enriched air during the entire examination.
|
|
|
|
|
|
Quantification of Aortic Flow Using MR Phase Velocity Mapping
Quantification of aortic flow using MR phase velocity mapping was performed once during breath-holding using a phase-contrast ECG-triggered two-dimensional fast-field echo sequence at the level of the PA, perpendicularly to the ascending aorta (AO). SV was evaluated using the Easy Vision 5.1. Circular regions of interest (ROI) were placed over the AO. The contours of the ROI were delineated around the internal border of the vessel of interest on all images by automated contour detection. SV (quantitative aortic flow [qf]-SV) was computed by integrating the flow over a complete cardiac cycle.
Contrast-Enhanced, Time-Resolved, Two-Dimensional MR Angiography of the Heart and Lungs for Calculation of the Peak Transit Time
Contrast-enhanced, time-resolved, two-dimensional MR angiography of the heart and lungs for calculation of the peak transit time (PTT) was performed twice in each patient for evaluation of reproducibility. A two-dimensional, T1-weighted, flow-compensated fast-field echo sequence was applied at the level of the pulmonary trunk and AO during IV gadolinium bolus injection (2 mL bolus of gadopentetate dimeglumine; Magnevist; Berlex Laboratories; Wayne, NJ), followed by 20 mL of saline solution, injected at a rate of 5 mL/s using an automated power injector (Spectris Solaris; Medrad; Indianola, PA). Two-dimensional data sets were acquired at 0.559- to 1.1-s intervals (approximately 2 Hz) for 25 to 30 s after contrast material injection. Subjects were requested to hold their breath in expiration during the MR angiographic examination for at least 30 s or as long as was comfortable. Time-intensity curves were generated for bolus transit through the ROI (Intera R 9.3; Philips Medical Systems): the outflow part of the PA and the AO. The PA and AO curves were fitted to functions describing peak/pulse curves (PA) and multicompartment impulse response exponential decay curves (AO) using software (Origin Version 7; Origin Lab Corporation; Northampton, MA). The PA-to-AO PTT was calculated by subtracting the time of peak signal intensity of the PA curve from that of the AO curve (Fig 2).
All hemodynamic data and data on cardiac dimensions were normalized to body surface area (BSA). ITBV index (ITBVI) was calculated as follows: qf-ITBVI = PTT x qf-cardiac output (CO)/60 x BSA.12 Furthermore, ITBVI was estimated from the contrast intensity vs time curves using a nonlinear mixed effect modeling (NONMEM) approach. The NONMEM program (version V, level 1.1; GloboMax LLC; Hanover, MD) with the first-order conditional estimation and interaction analysis procedure was used. The structural model of the lung used was a "tank in series" model. This type of model is suitable for describing intravascular peaks and has been used previously to describe the lung kinetics of the intravascular marker indocyanine green in man.13 Systemic vascular resistance index was calculated as mean arterial pressure/qf-cardiac index (CI).
Statistical Analysis
The reproducibility of PTT measurements and the agreement between the two methods for estimation of ITBVI were assessed according to Bland and Altman.14 An unpaired, two-tailed Student t test was used to compare the two groups. A linear regression analysis was performed to relate LVEDV index (LVEDVI) and cine-SVI to qf-ITBVI and cine-SVI to LVEDVI; p < 0.05 was considered to indicate statistically significant difference. Data are presented as mean ± SD.
Results
There were no differences between the groups regarding age, height, or weight (Table 1 ). The emphysema patients had the typical functional features of severe pulmonary emphysema: severe obstruction to expiratory airflow and considerable hyperinflation (Table 1).
|
|
|
|
Discussion
The main findings of this study were that cardiac performance was compromised in patients with severe pulmonary emphysema, as demonstrated by a lower SVI, when compared to control subjects matched for gender, age, and BSA. Although we have not proven a cause-effect relationship, the close relationship between ITBVI and LVEDVI and between LVEDVI and SVI (Fig 5, 6) strongly suggest that a low preload, caused by intrathoracic hypovolemia, contributes to the impaired LV performance seen in patients with severe emphysema. Furthermore, our data confirm the results from our previous study4 of anesthetized patients with severe emphysema studied with transesophageal two-dimensional Doppler echocardiography before and after lung volume reduction surgery. In that study, the emphysema group had a lower LV performance as demonstrated by a lower SVI and CI, associated with a lower baseline LV preload, as indicated by a lower LV end-diastolic area index and mitral Doppler flow indexes of impaired LV filling when compared to anesthetized nonemphysematous patients.4
A decreased ITBV compromising cardiac performance has, to our knowledge, not previously been demonstrated in patients with severe emphysema. Intrathoracic hypovolemia in patients with severe emphysema could be explained by the well-known dynamic hyperinflation and hence the generation of PEEPi seen in these patients.3151617 Tschernko et al3 showed that minimal PEEPi levels range from 5 to 7.5 cm H2O in patients with severe emphysema316 In the present study, we did not measure PEEPi or intrathoracic pressure, which is a major limitation of this study. However, our patients characteristics and lung function data were similar to those described by Tschernko et al.3 It would therefore seem reasonable that PEEPi levels were high also in the present study. In patients with normal lung function and in volunteers, positive pressure respiration with positive end-expiratory pressure depletes the intrathoracic vascular bed and the heart, decreasing both pulmonary vascular and RV and LV end-diastolic volumes.18192021222324 Furthermore, positive end-expiratory pressure induces changes in the mitral Doppler-derived indexes indicative of impaired LV filling.192425 One could speculate that the PEEPi-induced decrease in ITBV is caused by a decreased compliance of the pulmonary vascular bed in emphysema due to the hyperinflated lungs, which may redistribute blood to the periphery.
A reduction in ITBV could alternatively be explained by a diminution of the pulmonary vascular bed and a decreased pulmonary blood volume as a consequence of the disease, since all patients had severe emphysema. However, our suggestion that high PEEPi levels are of importance to explain the decreased ITBV in severe emphysema is supported by our findings that lung volume reduction surgery improves LV performance in emphysematous patients.4 This improvement is accompanied by an increase in LV end-diastolic area index and mitral Doppler flow indexes of improved LV filling.4 Lung volume reduction surgery is associated with an alleviation of PEEPi,231617 which thus could normalize a low ITBV, as well as low RV and LV end-diastolic blood volumes in these patients.
The lower RV and LV preload in patients with emphysema could be caused by external compression (pulmonary tamponade) from the hyperinflated lungs increasing end-diastolic stiffness. However, we have previously shown that the LV end-diastolic pressure-area relationship is not different from that seen in nonemphysematous patients, indicating that the hyperinflated lungs do not increase LV end-diastolic stiffness in patients with severe emphysema.4 Another mechanism for the impaired filling of the LV in patients with emphysema could be LV diastolic dysfunction caused by LV hypertrophy. However, LV wall mass is not increased in these patients with emphysema, as shown previously,2627 and by us in the present study. A third explanation for the low LVEDV in these patients could be a leftward shift of the interventricular septum, causing an underfilling of the LV, as has been shown in patients with primary pulmonary hypertension,28 and also in some patients with emphysema.26 This mechanism is less likely since the configuration of the interventricular septum did not differ between the groups. Furthermore, none of the patients in the present study had severe pulmonary hypertension (systolic PA pressure > 55 mm Hg), as evaluated by Doppler echocardiography, and none had RV hypertrophy.
Indirect evidence that the left ventricle of emphysema patients is hypovolemic in diastole is our recent study29 on patients with severe emphysema in which LV dimensions and performance were evaluated using transesophageal two-dimensional echocardiography and PA thermodilution catheter before and during central blood volume expansion by passive leg elevation. LV filling pressures and LV end-diastolic areas increased by 20 to 30% and 12 to 16%, respectively, which in turn caused a twofold- to threefold-greater increase in SV for a certain increase in preload, and a greater increase in LV area ejection fraction in patients with emphysema compared to control subjects. Thus, the left ventricle operates on a steeper portion of the Frank-Starling relationship in emphysema patients and thus has a less than optimal diastolic stretch of the myocardial sarcomeres at baseline. This could explain the lower LV and RV ejection fractions in the emphysema patients compared to control subjects in the present study.
We measured PTT by subtracting the times of peak AO and PA signal intensities30 rather than by subtracting the first moment of the curves to achieve mean transit time, which, by definition, is used for calculation of ITBV.12 However, it has been shown that PTT is an excellent approximate of mean transit time, PTT being < 4% higher than mean transit time.31 The utility of the PTT approach is supported by the NONMEM modeling analysis, which gave very similar results. The transit time of an indicator is proportional to its volume of distribution (ITBV) and inversely proportional to flow (CO), according to fundamental principles of tracer kinetics.32 In our study, PTT was not significantly different from control because the low CO, which would have increased PTT, was accompanied by a decreased ITBV, which will decrease PTT. In other words, the time for oxygen uptake is maintained in emphysema patients, in spite of the low CO, because of the low ITBV.
In all MRI procedures, errors may occur due to motion artifacts. Patients in the emphysema group were thus less likely to hold their breath during expiration for 25 to 30 s. In spite of this, contrast-enhanced, time-resolved, two-dimensional MR angiography provided PTT measurements with a high reproducibility in the present study. In addition, in our control group, PTT was 7.5 ± 1.6 s, which is comparable to 7.2 ± 1.2 s as shown by Shors et al30 in their control subjects.
In conclusion, we have shown that intrathoracic hypovolemia may explain why cardiac performance is impaired in patients with emphysema. Low SVs in these patients were associated with low LV and RV end-diastolic volumes and low ITBVs. These findings might have clinical implications in the perioperative hemodynamic management of these patients with respect to IV fluid therapy and to the hemodynamic response to positive pressure ventilation.
Footnotes
Abbreviations: AO = ascending aorta; BSA = body surface area; CI = cardiac index; CO = cardiac output; ITBV = intrathoracic blood volume; ITBVI = intrathoracic blood volume index; LV = left ventricular; LVEDV = left ventricular end-diastolic volume; LVEDVI = left ventricular end-diastolic volume index; LVSVI = left ventricular stroke volume index; MR = magnetic resonance; NONMEM = nonlinear mixed effect modeling; PA = pulmonary artery; PEEPi = intrinsic positive end-expiratory pressure; PTT = peak transit time; qf = quantitative aortic flow; ROI = regions of interest; RV = right ventricular; RVEDVI = right ventricular end-diastolic volume index; RVSVI = right ventricular stroke volume index; SV = stroke volume; SVI = stroke volume index
This study was supported by the Swedish Medical Research Council, No. 13156 and the Medical Faculty of Gothenburg.
No financial or other potential conflicts of interest exist for any of the authors.
Received for publication September 11, 2006. Accepted for publication December 10, 2006.
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |